IgG1 Isotype Control FITC Monoclonal Antibody (Clone MOPC-21) Reference: 10343-1 Host: Mouse • Applications: FC and IFM
Sotrovimab Reference: HY-P99340 Sotrovimab (VIR 7831) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease.
Cytokeratin Monoclonal FITC Antibody (Clone C-11) Reference: 10349-1 Host: Mouse, clone C-11 • Cross Reactivity: (+) Human cytokeratins 4, 5, 6, 8, 10, 13, and 18 • Application(s): FC and IF • Cytokeratins are intermediate filament polypeptides that provide cellular support to epithelial cells as well as contribute to more dynamic processes. Cytokeratins are differentially expressed in normal and cancer cells.
Porgaviximab Reference: HY-P99784 Porgaviximab is a monoclonal antibody that can be used Ebola infection research.
Adropin Polyclonal Antibody Reference: 10381-1 Immunogen: Thioredoxin fusion protein containing amino acids 34-76 of human adropin • Host: Rabbit • Species Reactivity: (+) Human • Applications: ELISA and WB
Atoltivimab Reference: HY-P99343 Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection.